SynBioBeta Speaker
Jonathan Good
Scentian Bio
CEO & Co-founder
Jonathan is the CEO and cofounder of Scentian Bio, combining synthetic biology and AI to digitize smell and taste. Inspired by the remarkable chemosensory abilities of insects, Scentian Bio is developing digital smell-sensors that unlock chemical information in real-time. From growing and processing food, to health diagnostics, to security and environmental monitoring, these digital smell-sensors can create remarkable new abilities for humanity.
Jonathan studied as a Rhodes Scholar at the University of Oxford where he wrote his thesis on innovation theory and won the George Webb Prize as the top graduate student in economics. He has since dedicated his career to unlocking innovation and impact as a serial entrepreneur and business leader. While living in San Francisco, Jonathan was the cofounder of 1000memories, a social history platform that was backed by Y-Combinator and Greylock before exiting to Ancestry.com. Jonathan is Entrepreneur in Residence at Sprout Agritech, a leading New Zealand deeptech early-stage investor. Jonathan has previously held senior leadership roles in global food companies, Fonterra and T&G Global, and also holds undergraduate degrees from the University of Auckland in Physics, Mathematics and Economics.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Jonathan
This Year
Session lineup still growing
Purchase Pass
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Purchase Pass
Featuring
Speaker Coming Soon
